Table 2.
The general prevalence of bacterial co-infections in COVID-19 patients admitted in ICU.
| Bacterial Isolates | n | % | |
|---|---|---|---|
| Gram-Positive bacteria (n = 39, 11.40%) | |||
| Staphylococcus aureus | MRSA | 4 | 1.16 |
| MSSA | 20 | 5.84 | |
| Enterococcus faecalis | Non-VRE | 8 | 2.33 |
| VRE | 1 | 0.29 | |
| Streptococcus agalactiae | 6 | 1.75 | |
| Gram-Negative bacteria (n = 303, 88.59%) | |||
| Escherichia coli | Non-CRE | 93 | 27.19 |
| CRE | 5 | 1.46 | |
| Klebsiella pneumoniae | Non-CRE | 68 | 19.88 |
| CRE | 16 | 4.67 | |
| Pseudomonas aeruginosa | 51 | 14.91 | |
| Acinetobacter baumannii | 49 | 14.32 | |
| Stenotrophomonas maltophilia | 5 | 1.46 | |
| Klebsiella oxytoca | 5 | 1.46 | |
| Citrobacter freundii | 4 | 1.16 | |
| Serratia liquefaciens | 4 | 1.16 | |
| Proteus vulgaris | 3 | 0.87 | |
MRSA: Methicillin-resistant S. aureus. MSSA: Methicillin sensitive S. aureus. VRE: Vancomycin resistant Enterobacteriaceae. CRE: Carbapenem resistant Enterobacteriaceae.